Cardiopulmonary effects of progestational agents in emphysematous rats.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D004195:Disease Models, Animal; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects*; D006976:Hypertension, Pulmonary / Q000517:prevention & control; D037102:Lectins / Q000494:pharmacology; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D011374:Progesterone / Q000494:pharmacology*; D011652:Pulmonary Circulation / Q000187:drug effects; D011656:Pulmonary Emphysema / Q000503:physiopathology* / Q000517:prevention & control; D011660:Pulmonary Heart Disease / Q000517:prevention & control; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D014132:Trachea / Q000601:surgery; D014655:Vascular Resistance / Q000187:drug effects
D037102:Lectins; D002245:Carbon Dioxide; D011374:Progesterone; D008525:Medroxyprogesterone; D010100:Oxygen